Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Metastatic Gastroesophageal Junction Adenocarcinoma × sintilimab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 2 Neoplasm Metastasis 1 Metastatic Gastroesophageal Junction Adenocarcinoma 1 Esophageal Squamous Cell Carcinoma 1 Colorectal Cancer Liver Metastasis 1 Cholangiocarcinoma 1

Interventions

sintilimab 1 HMPL-013 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06329973 2025-07-17

Fruquintinib in Combination With Sintilimab and CAPEOX as First-line Treatment for G/GEJ Cancer

Henan Cancer Hospital

Phase 1/2 Recruiting

Gastrointestinal

Metastatic Gastroesophageal Junction Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡